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Abstract
The etiology of Posner-Schlossman syndrome (PSS) remains unknown. The association of
human leukocyte antigens (HLA) allelic diversity with PSS has been poorly investigated. To
evaluate the association of allelic polymorphisms of class I HLA-A, -B and -C and class II
HLA-DRB1 and -DQB1 with PSS, 100 unrelated patients with PSS and 128 age- and ethni-
cally matched control subjects were recruited from a southern Chinese Han population.
Polymorphisms in exons 2–4 for HLA-A, -B, -C loci, exon 2 for HLA-DRB1 and exons 2,3 for
HLA-DQB1 were analyzed for association with PSS at allele and haplotype levels. The
allele frequency of HLA-C*1402 in PSS patients was significantly higher than that in con-
trols (P = 0.002, OR = 4.12). This association survived the Bonferroni correction (Pc = 0.04).
The allele frequency of HLA-B*1301 in PSS patients was lower than that in the control
group (P = 0.003, OR = 0.21), although this association did not survive the Bonferroni cor-
rection (Pc = 0.16). In PSS patients, the haplotype frequencies of HLA-A*1101~C*1402 and
B*5101~C*1402 were higher than that in controls (P = 0.03, OR = 4.44; P = 0.02, OR =
3.20; respectively), while the HLA-B*1301~C*0304 was lower than that in controls (P =
0.007, OR = 0.23), although these associations did not survive the Bonferroni correction
(Pc > 0.16). This study for the first time demonstrated that polymorphisms at the HLA-B and
HLA-C loci were nominally associated with PSS in the southern Chinese Han population.
Our results suggest that HLA-C*1402, A*1101~C*1402 and B*5101~C*1402might be risk
factors for PSS, whereas HLA-B*1301 plus B*1301~C*0304might be protective factors
against PSS, but even larger datasets are required to confirm these findings. Findings from
this study provide valuable new clues for investigating the mechanisms and development of
new diagnosis and treatment for PSS.
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Introduction
In 1948, Posner and Schlossman first reported glaucomatocyclitic crisis (GCC) and described
the key features of this syndrome. So GCC was usually called as Posner-Schlossman syndrome
(PSS) [1]. PSS is known as a self-limiting eye disease with benign prognosis, but the glaucoma-
tous impairment of visual function in some patients with PSS has been increasingly reported
[2,3].
The etiology of PSS has remained to be elucidated. Several factors including autonomic
defect, allergic conditions, viral infection and DNA oxidative damage of the trabecular mesh-
work have been postulated to contribute to the development of PSS [4–9]. The vascular theory
considers glaucomatous optic neuropathy to be a consequence of insufficient ocular blood sup-
ply, which can be a consequence of vascular endotheliopathy [10–13].
PSS has some clinical features of glaucoma and uveitis, such as the elevated intraocular
pressure (IOP) and keratic precipitates (KPs). Human leukocyte antigens (HLA) class I and
class II molecule were demonstrated to be significantly associated with uveitis and glaucoma
[14–26]. Many kinds of uveitis including anterior uveitis, multiple sclerosis-associated inter-
mediate uveitis, birdshot chorioretinitis and sympathetic ophthalmia have been associated
with class I HLA [14–22]. Acute anterior uveitis (AAU) is the most common form of intraoc-
ular inflammation, and approximately 50% of cases were HLA-B27 positive [14]. HLA-
B27-associated AAU was a distinct clinical entity that had wide-ranging medical significance
due to its ocular, systemic, immunologic, and genetic features [15–17]. HLA-A29-positive
can serve as one of the important indicators for clinical diagnosis of birdshot chorioretinitis
(BSCR). BSCR accounts for approximately 7% of posterior uveitis. BSCR was strongly associ-
ated with HLA-A29, and 85% to 95% of patients with BSCR possessed HLA-A29, with an
overall estimate of 90% in Caucasian or White French [18–22]. It is well known that some
uveitis syndromes, such as Behçet disease (BD) and Vogt-Koyanagi-Harada disease [14,15],
are associated with certain HLA types. Kang et al [23] reported that HLA-A0207, A2601
and A3004 were associated with increased risk of BD, while HLA-A3303 was associated
with decreased risk of BD. HLA-A0207, A2601, and A3004 were associated with skin
lesions and arthritis, with uveitis, and with vascular lesions, genital ulcers, and a positive
pathergy test, respectively. HLA-DR3 significantly increased in Mexican primary open angle
glaucoma (POAG) patients compared with controls [24]. HLA-DRB10407~DQB10302
haplotype have been significantly associated with POAG in Mexicans [25]. DR11 and DQ1
alleles have been reported to be significantly associated with POAG in an Italian population
[26].
The literature on the association between PSS and HLA is extremely limited. Only one
study by Hirose et al [27] reported that HLA-Bw54 and haplotype HLA-Bw54-Cw1 showed
significant association with PSS in a Japanese population, suggesting that immunogenetic fac-
tors may play an important role in the pathogenesis of PSS. However, the number of PSS
patients in the Japanese study (n = 22) was limited and only classical class I HLA (HLA-A,-B
and-C) were serologically typed at low resolution level [27].
To elucidate the role of HLA in the pathogenesis of PSS and provide potential molecular
markers for clinical diagnosis of PSS, we genotyped class I and II HLA at high resolution level
by sequencing based typing (SBT) in a southern Chinese sample of 100 patients with PSS and
128 control subjects and investigated the association of HLA allelic diversity with PSS.
HLA-B and -C & PSS
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Materials and Methods
Patients and control subjects
The study protocol was approved by the local institutional ethnics committee of Shenzhen Eye
Hospital and was in accordance with the tenets of the Declaration of Helsinki. Written
informed consent was obtained from all study participants after the nature of the study was
explained. One hundred unrelated patients with PSS attending the Clinic of Shenzhen Eye
Hospital were randomly enrolled between 2011and 2014. A presumptive diagnosis of PSS was
made based on the following criteria [1,10,28]: (1) more commonly in the individuals aged 20–
50 years with an equal gender distribution; (2) a history or record of unilateral recurrent tran-
sient episodes of elevated IOP higher than 21 mmHg and duration of attack varying from a few
hours to several weeks. IOP may reach 40 mmHg or more, and spontaneous remission usually
occurs; (3) mild cyclitis: a few white KPs accumulating in the lower half of the cornea, and min-
imal flare and/or a few inflammatory cells in the anterior chamber; (4) open iridocorneal angle
without peripheral anterior synechia; (5) a slight decrease in vision, no visual field defect and
normal optic disc at the early stage. Exclusion criteria included a history of ocular trauma, a
history of ophthalmic herpes simplex virus (HSV) or cytomegalovirus (CMV), ocular laser
treatment, or ophthalmic surgery before the diagnosis of PSS [10].
One hundred and twenty-eight unrelated healthy volunteer blood donors from Shenzhen
Blood Center who had normal IOP and optic disc were recruited as control subjects. All control
subjects had no KPs, no any history of eye diseases, and no any history of ophthalmic HSV or
CMV. The age, sex and ethnic background of the control group were matched with the case
group. All cases and controls were southern Han Chinese.
DNA extraction
Peripheral blood samples (5 mL) were collected from each participant, and were anticoagulated
with 5% EDTA and stored at -80°C. Genomic DNA was extracted from the peripheral blood
with a TECAN DNA workstation (Sweden). DNA purity and concentration were tested using
an Eppendorf spectral photometer.
Sequencing-based typing for HLA class I and II
Genomic DNA was used for SBT with the commercial AlleleSEQR HLA SBT kit (Atria Genet-
ics, San Francisco, CA) according the manufacturer’s instructions. PCR product was purified
using ExoSAP-IT (Atria Genetics). Exons 2, 3 and 4 for HLA-A,-B,-C loci, exon 2 for
HLA-DRB1 and exons 2 and 3 for HLA-DQB1 were sequenced in both directions on an ABI
3730 DNA Sequencer (Applied Biosystem, Foster City, CA). HLA genotypes were assigned in
four-digit level with the help of the ASSIGN 3.5 software (Conexio Genomics, Applecross, Aus-
tralia; S1 and S2 Figs). Synonymous mutations were not taken into account.
Statistical analysis
Allele frequencies were calculated by direct counting. The difference in allele frequency and sex
between cases and controls was tested by the χ2 test or Fisher’s exact test using SPSS (version
19.0, SPSS Inc., Chicago, IL). Independent-samples T test was used for the comparison of age
and IOP between the two groups. Haplotype inference was performed using Arlequin V3.5
with the following settings: ELB algorithm performed at the haplotype level, burnin 100000,
sampling interval 500, ave. prior alpha 0.01, and het. site influence zone 5. Multiple testings
were corrected using the Bonferroni method and the corrected P value (Pc) was calculated by
multiplying the P value with the number of tests performed. Pc< 0.05 was considered
HLA-B and -C & PSS
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statistically significant. Odds ratio (OR) and 95% confidence interval (CI) were estimated
whenever applicable.
Results
Demographic and clinical features of patients and control subjects
The mean (SD) age of PSS patients (n = 100) was 32.6 (7.9) years ranging from 18 to 50 years.
47.0% of the patients were female and 53.0% were male. In the control group (n = 128), the
mean (SD) age was 31.9 (7.3) years ranging from 19 to 50 years. 40.6% of the controls were
female and 59.3% were male. No significant difference in age and sex was found between the
patient group and control group (P = 0.58 and 0.34 respectively; Table 1). The mean (SD) IOP
of eyes with PSS was 42.2 (7.1) mmHg while 15.3 (2.4) mmHg in the control group. The IOP of
eyes with PSS was significantly higher than that in control subjects (P< 0.001; Table 1).
Allele frequencies of HLA-A,-B,-C,-DRB1 and-DQB1
The number of identified HLA-A,-B,-C,-DRB1 and-DQB1alleles were 20, 34, 20, 17 and 16
respectively in PSS patients. 16 HLA-A alleles, 38 HLA-B alleles, 22 HLA-C alleles, 16
HLA-DRB1 alleles and 16 HLA-DQB1 alleles were detected in control subjects (Tables 2 and
3). The genotype distributions of HLA-A,-B,-C-DRB1 and-DQB1 loci in both the patient and
control groups were in accordance with Hardy–Weinberg equilibrium (P> 0.24; data not
shown).
The allele frequency ofHLA-C1402 in patients with PSS was significantly higher than that
in control subjects (9.0% vs. 2.3%, P = 0.002, Pc = 0.04, OR = 4.12; Table 4). The allele fre-
quency of HLA-B1301 in the patient group was significantly lower than that in the control
group (2.0% vs. 9.0%, P = 0.003, OR = 0.21; Table 4), although this association did not survive
the Bonferroni correction (Pc = 0.16). No significant difference was found between PSS patients
and controls for the frequencies of HLA-A,-DRB1 and-DQB1 alleles (P> 0.05).
Haplotypefrequencies of HLA-A,-B,-C,-DRB1 and-DQB1
The haplotype frequencies of HLA-A1101~C1402 and B5101~C1402 in PSS patients were
significantly higher than that in controls (5.0% vs. 1.2%, P = 0.03, OR = 4.44; 6.0% vs. 2.0%,
P = 0.02, OR = 3.20; respectively; Table 4), although these associations did not survive the Bon-
ferroni correction (Pc> 0.52). The haplotype frequency ofHLA-B1301~C0304 in PSS
patients was significantly lower than that in controls (2.0% vs. 8.2%, P = 0.007, OR = 0.23;
Table 4), although this association did not survive the Bonferroni correction (Pc = 0.16). No
significant difference in the haplotype frequencies of the other loci was found between patients
with PSS and control subjects (P> 0.05).
Table 1. The demographic and clinical features of the PSS cases and controls.
Feature PSS (n = 100) Controls (n = 128) P
Age, mean (SD), year 32.6(7.9) 31.9(7.3) 0.58a
Sex (M/F) 53/47 76/52 0.34b
IOP, mean (SD), mmHg 42.2(7.1) 15.3(2.4) <0.001a
KPs (Y/N) Y N
Abbreviations: PSS, Posner-Schlossman syndrome; IOP, intraocular pressure;KPs, keratic precipitates.
a Independent-samples T test
b χ2 test.
doi:10.1371/journal.pone.0132179.t001
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Discussion
Conventional serological typing, PCR-based genotyping and direct sequencing of HLA genes
have revealed more specific HLA alleles associated with various eye diseases. However, the
association between PSS and HLA has been poorly investigated. To date, only one study by
Hirose et al.27 reported that HLA-Bw54 and haplotype HLA-Bw54-Cw1 showed significant
association with PSS in a small sample of the Japanese population. Despite of the limited sam-
ple size, the Japanese study suggests that immunogenetic factors closely associated with the
major histocompatibility complex may play an important role in the pathogenesis of PSS.
However, only class I HLA (HLA-A, B and C) were typed at low resolution level by serological
method in the Japanese study [27]. In the present study, we for the first time investigated the
association of class I and class II HLA diversity with PSS at high resolution level by sequencing
based typing in a larger sample of southern Chinese Han population.
In the present study, we found that the allele frequency of HLA-C1402 in patients with PSS
was significantly higher than that in the controls (OR = 4.12, 95% CI: 1.60–10.59; Table 4), sug-
gesting that HLA-C1402might be a risk factor for PSS. However, the allele frequency of
HLA-B1301 in PSS patients was significantly lower than that in the control group (OR = 0.21,
95% CI: 0.07–0.61; Table 4), suggesting thatHLA-B1301might be a protective factor for PSS.
We did not find significant difference in allele frequencies of the HLA-A,-DRB1 and-DQB1
Table 2. Frequencies of HLA-A and-B alleles in PSS cases and controls.
HLA-A* PSS Controls P HLA-B* PSS Controls P HLA-B* PSS Controls P
0101 2 (1.0) 2 (0.8) 0.80 0705 2 (1.0) 1 (0.4) 0.42 3701 0 2 (0.8) 0.34
0201 16 (8.0) 18 (7.0) 0.70 0801 1 (0.5) 1 (0.4) 0.86 3801 1 (0.5) 1 (0.4) 0.86
0203 5 (2.5) 16 (6.3) 0.06 1301 4 (2.0) 23 (9.0) 0.003 3802 5 (2.5) 8 (3.1) 0.69
0206 4 (2.0) 6 (2.3) 0.80 1302 1 (0.5) 4 (1.6) 0.28 3901 7 (3.5) 3(1.17) 0.09
0207 32 (16.0) 34 (13.3) 0.41 1501 4 (2.0) 12 (4.7) 0.12 4001 26 (13.0) 46 (18.0) 0.15
0301 0 4 (1.6) 0.12 1502 19 (9.5) 20 (7.8) 0.52 4002 4 (2.0) 1 (0.4) 0.10
1101 69 (34.5) 80 (31.3) 0.46 1507 0 1 (0.4) 0.59 4003 0 1 (0.4) 0.59
1102 8 (4.0) 12 (4.7) 0.72 1511 0 2 (0.8) 0.34 4006 1 (0.5) 7 (2.7) 0.07
1136 0 1 (0.4) 0.58 1512 2 (1.0) 0 0.17 4403 5 (2.5) 2 (0.8) 0.27
2402 26 (13.0) 38 (14.8) 0.57 1518 2 (1.0) 0 0.17 4601 41 (20.5) 39 (15.2) 0.14
2403 1 (0.5) 1 (0.4) 0.86 1519 0 1 (0.4) 0.59 4801 1 (0.5) 3 (1.2) 0.45
2404 1 (0.5) 0 0.37 1521 0 1 (0.4) 0.59 5101 13 (6.5) 7 (2.7) 0.05
2407 2 (1.0) 0 0.17 1525 2 (1.0) 0 0.17 5102 6 (3.0) 5 (2.0) 0.47
2408 1 (0.5) 0 0.37 1527 2 (1.0) 0 0.17 5201 0 3 (1.2) 0.20
2410 1 (0.5) 0 0.37 1558 0 1 (0.4) 0.59 5401 8 (4.0) 6 (2.3) 0.31
2601 3 (1.5) 6 (2.3) 0.52 1801 0 2 (0.8) 0.34 5502 11 (5.5) 8 (3.1) 0.21
2901 1 (0.5) 0 0.37 1802 1 (0.5) 0 0.37 5601 1 (0.5) 2 (0.8) 0.71
3001 2 (1.0) 4 (1.6) 0.61 2704 6 (3.0) 6 (2.3) 0.66 5603 1 (0.5) 0 0.37
3101 4 (2.0) 7 (2.7) 0.90 2705 2 (1.0) 1 (0.4) 0.42 5604 1 (0.5) 0 0.37
3201 1 (0.5) 3 (1.2) 0.45 2706 0 1 (0.4) 0.59 5701 1 (0.5) 0 0.37
3303 20 (10.0) 24 (9.4) 0.82 2707 0 1 (0.4) 0.59 5801 13 (6.5) 22 (8.6) 0.40
6801 1(0.5) 0 0.37 3501 2 (1.0) 4 (1.6) 0.60 6701 0 1 (0.4) 0.59
3503 0 5 (2.0) 0.08 7801 1 (0.5) 0 0.37
3505 3 (1.5) 2 (0.8) 0.46
The allele frequencies were presented as allele count (%). Abbreviations: PSS, Posner-Schlossman syndrome; χ2 test was used.
doi:10.1371/journal.pone.0132179.t002
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loci between the PSS group and the control group (Tables 2 and 3), indicating that these HLA
loci might not contribute to the development of PSS.
HLA-B1301~C0304is a common haplotype in our samples of southern Chinese Han pop-
ulation, with a relatively high frequency of 8.2% (Table 4). Notably, the HLA-B1301 allele was
Table 3. Frequencies of HLA-C,-DQB1 and-DQB1 alleles in PSS cases and controls.
HLA-C* PSS Controls P HLA-DRB1* PSS Controls P HLA-DQB1* PSS Controls P
0102 55 (27.5) 51 (19.9) 0.06 0101 1 (0.5) 0 0.37 0201 10 (5.0) 14 (5.5) 0.82
0103 1 (0.5) 0 0.37 0301 10 (5.0) 14 (5.5) 0.82 0202 4 (2.0) 7 (2.7) 0.84
0108 0 1 (0.4) 0.59 0401 1 (0.5) 1 (0.4) 0.86 0301 46 (23.0) 52 (20.3) 0.49
0202 2 (1.0) 1 (0.4) 0.42 0403 2 (1.0) 6 (2.3) 0.28 0302 14 (7.0) 15 (5.9) 0.62
0302 13 (6.5) 21 (8.2) 0.49 0404 2 (1.0) 0 0.17 0303 44 (22.0) 46 (18.0) 0.28
0303 11 (5.5) 13 (5.1) 0.84 0405 13 (6.5) 21 (8.2) 0.49 0401 11 (5.5) 20 (7.8) 0.33
0304 19 (9.5) 39 (15.2) 0.07 0406 8 (4.0) 7 (2.7) 0.45 0402 1 (0.5) 3 (1.2) 0.45
0401 9 (4.5) 15 (5.9) 0.52 0407 0 1 (0.4) 0.59 0501 5 (2.5) 9 (3.5) 0.73
0403 1 (0.5) 3 (1.2) 0.45 0701 5 (2.5) 8 (3.1) 0.91 0502 19 (9.5) 28 (10.9) 0.62
0406 0 1 (0.4) 0.59 0801 1 (0.5) 0 0.37 0503 9 (4.5) 11 (4.3) 0.92
0415 0 1 (0.4) 0.59 0802 1 (0.5) 2 (0.8) 0.71 0601 20 (10.0) 30 (11.7) 0.56
0602 2 (1.0) 6 (2.3) 0.28 0803 14 (7.0) 14 (5.5) 0.50 0602 10 (5.0) 10 (3.9) 0.57
0701 1 (0.5) 1 (0.4) 0.86 0809 0 1 (0.4) 0.59 0603 1 (0.5) 2 (0.8) 0.71
0702 26 (13.0) 43 (16.8) 0.26 0901 42 (21.0) 45 (17.6) 0.36 0604 1 (0.5) 2 (0.8) 0.71
0704 2 (1.0) 1 (0.4) 0.86 1001 1 (0.5) 3 (1.2) 0.80 0609 4 (2.0) 5 (2.0) 0.97
0801 23 (11.5) 27 (10.6) 0.75 1101 7 (3.5) 10 (3.9) 0.82 0610 1 (0.5) 2 (0.8) 0.71
0803 1 (0.5) 1 (0.4) 0.86 1104 1 (0.5) 0 0.37
1202 6 (3.0) 8 (3.1) 0.94 1201 10 (5.0) 8 (3.3) 0.31
1203 3 (1.5) 8 (3.1) 0.26 1202 26 (13.0) 27 (10.6) 0.42
1402 18 (9.0) 6 (2.3) 0.002 1301 0 2 (0.8) 0.34
1403 2 (1.0) 1 (0.4) 0.42
1502 3 (1.5) 7 (2.7) 0.37
1505 2 (1.0) 0 0.17
1701 0 1 (0.4) 0.59
The allele frequencies were presented as allele count (%). Abbreviations: PSS, Posner-Schlossman syndrome; χ2 test was used.
doi:10.1371/journal.pone.0132179.t003
Table 4. Significant alleles and haplotypes associated with PSS.
PSS (2n = 200) Controls (2n = 256)
HLA- Count Frequency (%) Count Frequency (%) P Pc OR (95% CI)
Allele
B*1301 4 2.0 23 9.0 0.003 0.16 0.21 (0.07–0.61)
C*1402 18 9.0 6 2.3 0.002 0.04 4.12 (1.60–10.59)
Haplotype
A*1101~C*1402 10 5.0 3 1.2 0.03 0.84 4.44 (1.21–16.35)
B*5101~C*1402 12 6.0 5 2.0 0.02 0.52 3.20 (1.11–9.25)
B*1301~C*0304 4 2.0 21 8.2 0.007 0.16 0.23 (0.08–0.68)
Abbreviations: PSS, Posner-Schlossman syndrome; Pc, Bonferroni corrected P value by multiplying the P value with the number of tests performed; CI,
conﬁdence interval; OR, odds ratio; χ2 test was used.
doi:10.1371/journal.pone.0132179.t004
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in strong linkage disequilibrium with theHLA-C0304 allele. Among a total of 23HLA-B1301
alleles identified in the control group, 21 alleles linked withHLA-C0304, and all the 4
HLA-B1301 alleles in the PSS group linked withHLA-C0304. Our results showed that the
haplotype frequency ofHLA-B1301~C0304 in PSS patients was significantly lower than that
in controls PSS (OR = 0.23; 95% CI: 0.08–0.68; Table 4), indicating that individuals carrying
this haplotype might have a reduced risk to develop PSS.
In this study, we identified two high-risk haplotypes,HLA-A1101~C1402 and
B5101~C1402 (OR = 4.44 and 3.20 respectively; Table 4). Intriguingly, both of the haplotypes
were associated with HLA-C1402, which is in accordance with thatHLA-C1402 was associ-
ated with increased risk of developing PSS.
The HLA-B27 allele was relatively rare in our study, accounting for only 4.0% (3.0%
HLA-B2704 and 1.0% HLA-B2705) of the PSS patients and 3.5% (2.3% HLA-B2704, 0.4%
HLA-B2705, 0.4% HLA-B2706 and 0.4% HLA-B2707) of the controls (Table 2). In contrast
to the findings that HLA-B27 is associated with acute anterior uveitis [14–17], our results
showed that HLA-B27 was not significantly associated with PSS, suggesting that PSS and AAU
might be different uveitis. In addition, we did not find significant associations between PSS and
HLA-DRB1or HLA-DQ B1, which have been associated with POAG in Mexicans [25]. Collec-
tively, these findings indicate that there might be different pathogenesis between PSS and AAU
or POAG.
It has been reported that ophthalmic HSV or CMV infection might be associated with PSS
[5–7, 29]. In the present study, all cases and control subjects had no any history of ophthalmic
HSV or CMV. Therefore, our findings that the HLA-B and HLA-C polymorphisms are associ-
ated with PSS are unlikely to be confounded by the possible association of ophthalmic HSV or
CMV infection with PSS.
Conclusions
In summary, the present study for the first time demonstrated that the allelic polymorphisms
of HLA were nominally associated with PSS in southern Chinese Han population. Our results
suggest that gene polymorphisms at the HLA-B and HLA-C loci might contribute to develop-
ing PSS but even larger datasets are required to confirm these findings. Specifically,
HLA-C1402, A1101~C1402 and B5101~C1402might predispose to PSS, while
HLA-B1301, especially B1301~C0304might be protective against PSS. These findings will
provide valuable new clues for investigation into the mechanisms and development of new
diagnosis and treatment for PSS.
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